Navigation Links
Kensey Nash to Present at the Canaccord Adams Musculoskeletal Conference
Date:2/13/2009

EXTON, Pa., Feb. 13 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Canaccord Adams Musculoskeletal Conference at the University of Nevada in Las Vegas on Tuesday, February 24, 2009.

Douglas G. Evans, Kensey Nash's Chief Operating Officer, will deliver the Company's presentation, beginning at approximately 1:00 p.m. (ET). The presentation materials will be available on the company's website (www.kenseynash.com) beginning at 1:00 p.m. (ET) on Tuesday, February 24, 2009. Also, the entire Canaccord Adams Musculoskeletal Conference will be available in an audio-only webcast. To listen to the webcast, you must go to http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2550240. The webcast will be made available by the end of the day on Tuesday, February 24, 2009 and be maintained for three months.

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily sports medicine, spine, and endovascular markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of medical devices and absorbable biomaterials, which has led to partnerships to commercialize technologies.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
2. Kensey Nash Announces $25 Million Stock Repurchase Program
3. Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares
4. Kensey Nash Reports First Quarter Fiscal Year 2008 Results
5. Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
6. Kensey Nash to Present at the 19th Annual Piper Jaffray Health Care Conference
7. Kensey Nash Corporation Announces Its Second Quarter 2008 Earnings Release Date and Teleconference
8. Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million
9. Kensey Nash to Participate in the Sidoti Twelfth Annual New York Emerging Growth Institutional Investor Forum Conference
10. Kensey Nash Reports Third Quarter Record Revenue and Sales
11. Kensey Nash to Present at the Bank of America 2008 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... (Dec. 3, 2016) , ... (PRWEB) December 07, ... ... only patient advocacy nonprofit for individuals impacted by cerebral cavernous angiomas, was awarded ... New Mexico with a patient engagement program. New Mexico has more people with ...
(Date:12/7/2016)... ... December 07, 2016 , ... Dr. ... at the International Probiotic Association’s Washington DC workshop on November 2nd. The conference ... in dialog regarding probiotic dietary supplement regulations. , Dr. Leyer spoke about ...
(Date:12/7/2016)... ... December 07, 2016 , ... "Hacking into my medical record wouldn’t be ... 'a genius.'" Thus begins "Margaret in Berlin," Book Twelve in the Margaret of ... Books, Inc. These novels narrate the lives of a poor teenager and her ...
(Date:12/6/2016)... , ... December 06, 2016 , ... ... agreed to collaborate in developing a vaccine against the Middle East Respiratory Syndrome ... can be available in South Korea for emergency deployment in the event of ...
(Date:12/6/2016)... ... December 06, 2016 , ... Individuals who seek to reduce ... drinking more water or limiting their exposure to the sun, according to a November ... group Beverly Hills Physicians (BHP) notes that, while preventive measures to help keep ourselves ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... DIEGO , Dec. 6, 2016  Arcturus ... RNA medicines company, announced today that it entered ... develop RNA-based therapeutics for the treatment of NASH ... wholly-owned therapeutic delivery platform LUNAR™ and UNA Oligomer ... "Given Takeda,s long-standing commitment to and expertise ...
(Date:12/6/2016)... OCEAN VIEW, Delaware , December 6, 2016 ... 2024; as per a new research report by Global Market Insights, Inc. ... ... GMI logo ... Increasing global population, growing women employment rates and rising consumer ...
(Date:12/5/2016)... 5, 2016  Balloon catheter is an innovative medical ... into the femoral artery in the leg or sometimes ... constricted blood vessels. These products are generally used to ... deposition of lipid substances in the blood vessel. In ... projected to expand at a CAGR of 3.8% during ...
Breaking Medicine Technology: